Detail akcie Sartorius AG Preferred Stock online

Business Summary: Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Sartorius AG revenues increased 5% to EUR3.54B. Net income applicable to common stockholders increased 84% to EUR154.9M. Revenues reflect Bioprocess Solutions segment increase of 7% to EUR2.87B, Europe (Region)-Germany (Country)-France (Country) segment increase of 7% to EUR999.1M, United States (Country) segment increase of 5% to EUR1.16B.